Nealon Communicators’ Lectures Honor Late NCI Employee

Publication
Article
Oncology NEWS InternationalOncology NEWS International Vol 9 No 2
Volume 9
Issue 2

BETHESDA, Md-The National Cancer Institute has named a new lecture series for Eleanor Nealon, a long-time employee who died of recurrent breast cancer on Oct. 22.

BETHESDA, Md—The National Cancer Institute has named a new lecture series for Eleanor Nealon, a long-time employee who died of recurrent breast cancer on Oct. 22.

The Eleanor Nealon Extraordinary Communicators’ Lecture Series will focus on the communication of science to the public and will feature “outstanding communicators who have advanced an understanding of science through their skill in communications.” Three speakers will be selected each year, drawn from the areas of technology, business, academia, the media, and the advocacy community. Ms. Nealon was an 18-year employee of the Institute. Prior to her death, she served as director of the NCI Office of Liaison

Recent Videos
Leading experts in the breast cancer field highlight the use of CDK4/6 inhibitors, antibody-drug conjugates, and other treatment modalities.
Patients with node-negative disease who are older and have comorbidities may not be suitable to receive CDK4/6 inhibitors.
An observed carryover effect with CDK4/6 inhibitors may reduce the risk of recurrence years after a patient stops treatment.
Breast oncologist Jade E. Jones, MD, says she tries to send patients with BRCA-mutant HR-positive TNBC to clinical trials that use PARP inhibitors.